In 2014, CHAI supported the governments of Nigeria, Cameroon, Uganda, Kenya, Malawi, and Zambia to switch from quinine to injectable artesunate, which is estimated to save more than 25,000 lives versus treatment with quinine. CHAI supported quantification and procurement that resulted in orders placed for over 6.8 million vials of injectable artesunate, enough to treat over 1 million severe malaria patients.